Ontology highlight
ABSTRACT:
SUBMITTER: Franco-Molina MA
PROVIDER: S-EPMC8056056 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Franco-Molina Moisés Armides MA Santana-Krímskaya Silvia Elena SE Madrigal-de-León Luis Mario LM Coronado-Cerda Erika Evangelina EE Zárate-Triviño Diana Ginette DG Hernández-Martínez Sara Paola SP García-Coronado Paola Leonor PL Rodríguez-Padilla Cristina C
EXCLI journal 20210309
Glioblastoma multiforme is a malignant neoplasm of the brain with poor prognosis. The first-line drug against glioblastoma is the alkylating agent temozolamide (TMZ); unfortunately, treatment resistance and tumor re-incidence are common. In some cases, immunogenic cell death (ICD) inducers can decrease treatment resistance and tumor recurrence by stimulating an antitumor specific immune response. Not all ICD inducers, however, are suitable for glioma patients because of the low permeability of t ...[more]